WO2007015265A3 - Fabrication de 6,9-imino ether - Google Patents
Fabrication de 6,9-imino ether Download PDFInfo
- Publication number
- WO2007015265A3 WO2007015265A3 PCT/IN2006/000180 IN2006000180W WO2007015265A3 WO 2007015265 A3 WO2007015265 A3 WO 2007015265A3 IN 2006000180 W IN2006000180 W IN 2006000180W WO 2007015265 A3 WO2007015265 A3 WO 2007015265A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ether
- erythromycin
- lmino
- preparing
- imino ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Procédé de fabrication de 6,9-imino éther à partir de thiocyanate d'érythromycine sans isolement d'une base d'érythromycine et d'un oxime d'érythromicine, dans lequel un réagencement Beckmann d'oxime d'érythromycine a lieu avec un système de solvant biphasique comprenant du chlorure de méthylène et de l'eau en présence de triéthylamine et de bicarbonate de soude, le but étant d'obtenir un 6,9-Imino éther pur à 87-96 %. Le 6,9-imino éther est ensuite hydrogéné en 9-déoxo-9a-aza-9a-homoérythromycine, puis soumis à une méthylation réductive pour obtenir un dihydrate d'azithromicine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN627/MUM/2005 | 2005-05-24 | ||
| IN627MU2005 | 2005-05-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007015265A2 WO2007015265A2 (fr) | 2007-02-08 |
| WO2007015265A3 true WO2007015265A3 (fr) | 2007-12-06 |
Family
ID=37709013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2006/000180 Ceased WO2007015265A2 (fr) | 2005-05-24 | 2006-05-24 | Fabrication de 6,9-imino ether |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007015265A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090054634A1 (en) * | 2007-08-09 | 2009-02-26 | Vinod Kumar Kansal | Process for the preparation of clarithromycin |
| WO2009156938A2 (fr) * | 2008-06-24 | 2009-12-30 | Alembic Limited | Procédé économique pour préparer de l'éther 6,9-imino |
| US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| CN105481913B (zh) * | 2014-09-19 | 2019-01-08 | 宁夏启元药业有限公司 | 一种合成阿奇霉素的方法 |
| CN106083954B (zh) * | 2016-06-22 | 2018-12-11 | 连云港笃翔化工有限公司 | 一种红霉素6,9亚胺醚化合物的制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994026758A1 (fr) * | 1993-05-19 | 1994-11-24 | Pfizer Inc. | Intermediaire s'appliquant a l'azithromycine |
| US20010047089A1 (en) * | 2000-01-04 | 2001-11-29 | Judith Aronhime | Preparation method of azithromycin dihydrate |
| WO2002044193A1 (fr) * | 2000-11-30 | 2002-06-06 | Ercros Industrial, S.A. | Procédé permettant d'obtenir de l'azaérythromycine |
| EP1469008A1 (fr) * | 2000-03-15 | 2004-10-20 | Hanmi Pharm. Co., Ltd. | Procédé de préparation de crystaux de clarithromycine de qualité non pharmaceutique |
-
2006
- 2006-05-24 WO PCT/IN2006/000180 patent/WO2007015265A2/fr not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994026758A1 (fr) * | 1993-05-19 | 1994-11-24 | Pfizer Inc. | Intermediaire s'appliquant a l'azithromycine |
| US20010047089A1 (en) * | 2000-01-04 | 2001-11-29 | Judith Aronhime | Preparation method of azithromycin dihydrate |
| EP1469008A1 (fr) * | 2000-03-15 | 2004-10-20 | Hanmi Pharm. Co., Ltd. | Procédé de préparation de crystaux de clarithromycine de qualité non pharmaceutique |
| WO2002044193A1 (fr) * | 2000-11-30 | 2002-06-06 | Ercros Industrial, S.A. | Procédé permettant d'obtenir de l'azaérythromycine |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE CASREACT STN INTERNATIONAL, KARLSRUHE; 2003, QIN N.: "Study on the processes for preparation roxithromycin" * |
| GUANGDONG YAOXUE, vol. 13, no. 6, pages 23 - 24 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007015265A2 (fr) | 2007-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2657483A1 (fr) | Procede de synthese de macrolides | |
| WO2005021566A3 (fr) | Pyrazoles glucopyranosyloxy, medicaments contenant ces composes, leur utilisation et leur procede de production | |
| FR2859996B1 (fr) | Solvat acetonique du dimethoxy docetaxel et son procede de preparation | |
| TW200745149A (en) | Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments | |
| CL2008002966A1 (es) | Compuesto tetrapeptido ceto-epoxido cristalino; sal citrato cristalina del compuesto; metodos de preparacion; compuesto intermediario cristalino; metodo de preparacion; y uso para tratar cancer, enfermedad autoinmune, afeccion relacionada con trasplante, enfermedad neurodegenerativa, afeccion asociada con fibrosis, entre otros. | |
| WO2004075823A3 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
| DE602005012126D1 (de) | C-aryl-glucosid-sglt2-inhibitoren und verfahren zu ihrer herstellung | |
| EP1075837A3 (fr) | Procédé de préparation de formulations aqueuses pour usage ophtalmique | |
| ZA200706392B (en) | Intermediate and process for preparing of beta-anomer enriched 21-deoxy-21, 21 - difluoro-D-ribofuranosyl nucleosides | |
| FR2934596B1 (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
| DE60128296D1 (de) | Saccharid-Alkylenoxyderivate und Tinte | |
| HRP20130768T1 (en) | Use of cyclohexanehexol derivatives in the treatment of ocular diseases | |
| WO2007015265A3 (fr) | Fabrication de 6,9-imino ether | |
| Sugawara et al. | Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents | |
| MY150408A (en) | P-TOLUENE SULFONIC ACID SALT OF 5-AMINO-3-(2'-O-ACETYL-3'-DEOXY-ß-D-RIBOFURANOSYL)-3H-THIAZOLE[4,5-D]PYRIMIDINE-2-ONE AND METHODS FOR PREPARATION | |
| WO2002042315A3 (fr) | Solvates macrolides | |
| IL155667A0 (en) | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine | |
| TNSN04166A1 (en) | Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a | |
| AU2003290544A8 (en) | System to produce sugar from sugar cane | |
| EP3209674A1 (fr) | Synthèse de macrolides anthelmintiques | |
| Nagai et al. | Synthesis of 4 ″-alkoxy avermectin derivatives using rhodium carbenoid-mediated O–H insertion reaction | |
| Gao et al. | The first total synthesis of 7-O-β-d-glucopyranosyl-4′-O-α-l-rhamnopyranosyl apigenin via a hexanoyl ester-based protection strategy | |
| CN103421063B (zh) | 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法 | |
| MX2010005999A (es) | Intermediarios en la sintesis de analogos de macrolidos de zearalenona. | |
| KR100372254B1 (en) | Erythromycin a 9-o-pseudosaccharinyl oxime derivative and process for preparing clarithromycin using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06809929 Country of ref document: EP Kind code of ref document: A2 |